2m 2m 2m 2m 2m 2m 2m
Phibro Animal-A (PAHC)
NASDAQ
$35.16+$0.52 (+1.50%)
Price as of Nov 11, 2026 7:55 PM EST- $731.1MMarket Cap
- -22.63%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Phibro Animal-A (PAHC)
$35.16+$0.52 (+1.50%)
PAHC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $34.64 | ||
Change | +$0.03 (+0.09%) | ||
Open | $34.48 | ||
High | $35.24 | ||
Low | $33.98 | ||
Previous Close | $34.61 | ||
Volume | 223,791 | ||
30-Day Average Volume | 217,852 | ||
1-Week Change | -7.99% | ||
1-Month Change | -9.56% | ||
1-Year Change | -22.63% | ||
3-Year Change | 282.36% | ||
5-Year Change | 74.85% | ||
Fundamentals | |||
Shares Outstanding | 21.1M | ||
Total Assets | $1.5B | ||
Market Cap | $731.1M | ||
Enterprise Value | $1.4B | ||
Period: QTR TTM FY | |||
Revenue | $386.8M | ||
Net Income | $29.5M | ||
Free Cash Flow | $7.3M | ||
EBIT | $50.1M | ||
EBITDA | $63.6M | ||
Net Working Capital | $649.4M | ||
EPS | $0.72 | ||
Enterprise Value/EBITDA | 22 | ||
Enterprise Value/Revenue | 4 | ||
P/B | 2 | ||
P/E | 48 | ||
PEG | 1 | ||
Price/Free Cash Flow | 100 | ||
Price/Operating Cash Flow | 28 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 1.39% | ||
Trailing Annual Dividend Yield | 1.39% | ||
Ex-Dividend Date | 11/25/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield